Browsing Tag
ASX
164 posts
Auravelle Metals expands Sheoak gold narrative as ASX:AUV tests scale at Nuckulla Hill
Auravelle Metals expands the Sheoak gold trend at Nuckulla Hill as ASX:AUV rises. Find out what the update means for investors today!
Peter Warren’s Wakeling deal hits ACCC Phase 2 as ASX:PWR faces a tougher consolidation test
Peter Warren’s Wakeling deal has entered ACCC Phase 2 as ASX:PWR faces margin pressure. Find out what this means for investors today!
Why is Elliott’s stake in Northern Star Resources (NST) now a major ASX gold sector signal?
Elliott’s A$1bn Northern Star stake puts ASX under pressure. The real question is whether governance, operations or M&A moves first.
Lode Resources may have found more than antimony at Montezuma. What does it mean for ASX:LDR investors?
Lode Resources adds silver-zinc upside at Montezuma as ASX:LDR trades near lows. Can Tasmania turn discovery into scale? Read more.
G50 Corp (ASX: G50) extends Golconda mineralisation to 1.3 km as Arizona critical minerals story gains weight
G50 Corp has extended Golconda mineralisation to 1.3 km in Arizona. Find out why ASX investors are watching the gallium angle.
PlaySide Studios (ASX: PLY) faces Meta contract shock as ASX tests investor confidence
Find out how PlaySide Studios’ Meta contract update could reshape ASX revenue, investor sentiment, and gaming-sector risk today!
Is Acrux Limited (ACR) quietly turning Lenzetto into a bigger ASX microcap catalyst?
Find out how Acrux Limited’s Lenzetto Australia licensing deal could reshape its ASX microcap story and women’s health strategy today!
Amplia Therapeutics (ASX: ATX) stock faces its next big test as narmafotinib moves deeper into cancer trials
Find out how Amplia Therapeutics’ FY2026 report frames ASX: ATX, narmafotinib trials, cash runway and investor sentiment today!
Cettire expands China presence with Tmall Global partnership as ASX: CTT eyes luxury e-commerce rebound
Find out how Cettire Limited’s Tmall Global partnership could reshape its China luxury e-commerce strategy after a sharp ASX: CTT rally.
Fisher & Paykel Healthcare (ASX: FPH) tops gainers as FY26 result lands and tariff refund opens
Fisher & Paykel Healthcare just beat. The harder question is whether a US Supreme Court tariff ruling hands FPH a refund or another year of uncertainty.